A patient arrives at the pharmacy expecting their usual insulin refill, only to discover the box, brand name, and pen device suddenly look different. The pharmacist explains that the medication is an interchangeable biosimilar approved for automatic substitution. Although the insulin is considered clinically equivalent, the unexpected switch can still …
Read More »Once-Weekly Basal Insulin: Does Simplicity Improve Adherence?
The arrival of a once-weekly basal insulin option marks one of the most meaningful advances in insulin therapy in decades. For years, daily basal injections have been the standard of care for people with type 1 and type 2 diabetes. However, many patients struggle with adherence, missed doses, and therapeutic …
Read More »Reimagining Remission: Can Short‑Term Intensive Therapy Reset Type 2 Diabetes?
Could the conventional “lifelong treatment” model for type 2 diabetes be rethought? Recent trials suggest that short‑term intensive therapy may offer more than transient glycemic control—it might trigger lasting remission in newly diagnosed patients. Such interventions, combining aggressive pharmacologic therapy or insulin with lifestyle change, show potential to preserve β‑cell …
Read More »The Case for Early Insulin: Rethinking Delayed Initiation in Type 2 Diabetes
Starting insulin early in the course of type 2 diabetes may seem counter‑intuitive. After all, many patients and clinicians treat insulin as a “last resort.” Yet what if early insulin initiation could actually change the trajectory of the disease — preserving pancreatic function, improving long‑term control, and reducing complications? In …
Read More »What is Insulin Therapy?
Discover the essentials of insulin therapy, a crucial diabetes treatment that regulates blood sugar and prevents complications.
Read More »New Frontiers in Insulin Resistance: What Patients and Clinicians Need to Know
Explore new insights in insulin resistance, crucial for patients and clinicians, enhancing understanding and treatment strategies in metabolic health.
Read More »New Once‑Weekly Insulin Efsitora Reduces Treatment Burden While Matching Glargine Efficacy in Type 2 Diabetes
Discover Insulin Efsitora: a once-weekly insulin matching glargine's efficacy, reducing treatment burden for type 2 diabetes patients.
Read More »Understanding Insulin Therapy for Type 1 Diabetes
Explore the essentials of insulin therapy for type 1 diabetes, its types, and personalized approaches for effective blood glucose management.
Read More »Celebrating Insulin Safety Week: Best Practices for Type 2 Diabetes Care
Join Insulin Safety Week to enhance awareness on safe insulin use, vital for diabetes management. Empower through education and collaboration.
Read More »Information on Insulin Glargine For Diabetes Patients
Explore the role of insulin glargine in diabetes care, offering steady blood sugar control and reduced hypoglycemia risk for effective management.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.